Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, reports on the implications for MedTech of the new NHS
The Department of Health and Social Care, the office of the Prime Minister Sir Keir Starmer and Health Secretary Wes Streeting have officially announced the launch of the government’s 10 Year Plan for the National Health Service (NHS). The 10 Year Health Plan is part of the government’s health missi
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, reports on early announcements of the new NHS 10 Year
Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, has announced the first cases of the VELYS Robotic-Assisted Solution for use in Unicompartmental Knee Arthroplasty (UKA) procedures in Europe. The expanded indication builds upon the VELYS Robotic-Assisted Solutio
Welsh renewable energy company Dulas is helping to protect millions of people against preventable diseases in developing countries with backing from UK Export Finance (UKEF) – the government’s export credit agency – and HSBC UK. The Machynlleth-based company developed the world’s first mass-produced
PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight Dx—its digital pathology image management system—for use in primary diagnosis in clinical settings
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, reports on steps to facilitate innovation in MedTech.
GP practices across England can now access new technology with the introduction of the first new core IT system for 25 years. As part of reforms to increase competition and innovation in the market, NHS England has approved the first of a new generation of electronic patient record systems for GPs –
Real-world study demonstrates next-gen EpiSwitch PSE blood test safely reduces unnecessary biopsies by up to 79% while accurately detecting prostate cancer. A real-world study published high-impact journal Cancers demonstrates the transformative potential of a next-generation prostate cancer blood t
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre, reports on European Union plans to digitise access to
JEB Technologies and Medovate, two medical device development and commercialisation companies based in East Anglia, have signed a distribution agreement with Murray Medical Solutions Pty Ltd, granting rights to distribute CamPROBE (The Cambridge Prostate Biopsy Device) across Australia and New Zeala
Researchers at Chalmers University of Technology in Sweden and the University of Auckland in New Zealand have developed a groundbreaking bioelectric implant that restores movement in rats after injuries to the spinal cord. This breakthrough offers new hope for an effective treatment for humans suffe
